<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35215294</PMID><DateRevised><Year>2022</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1424-8247</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Pharmaceuticals (Basel, Switzerland)</Title><ISOAbbreviation>Pharmaceuticals (Basel)</ISOAbbreviation></Journal><ArticleTitle>Human Enterovirus B: Selective Inhibition by Quinoxaline Derivatives and Bioinformatic RNA-Motif Identification as New Targets.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">181</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ph15020181</ELocationID><Abstract><AbstractText>The Enterovirus genus includes many viruses that are pathogenic in humans, including Coxsackie viruses and rhinoviruses, as well as the emerging enteroviruses D68 and A71. Currently, effective antiviral agents are not available for the treatment or prevention of enterovirus infections, which remain an important threat to public health. We recently identified a series of quinoxaline derivatives that were provento be potent inhibitors of coxsackievirus B5, the most common and a very important human pathogen belonging to the enterovirus genus. We have shown how most active derivatives interfere with the earliest stages of viral replication, blocking infection. Considering the broad antiviral spectrum, a very attractive property for an antiviral drug, we aimed to investigate the antiviral activity of the most promising compounds against other Enterovirus species. Here, we investigated the susceptibility of a panel of representatives of Enterovirus genus (enterovirus A71, belonging to A species; coxsackieviruses B4 and B3;echovirus 9, belonging to B species; and enterovirus D68, belonging to D species) to quinoxaline inhibitors. We also tested cytotoxicity and selectivity indices of the selected compounds, as well as their effects on virus yield.We also investigated their potential mechanism of action by a time course assay. In addition, a bioinformatic analysis was carried out to discover potential new conserved motifs in CVB3 and CVB4 compared to the other enterovirus species that can be used as new targets.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Madeddu</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7005-8329</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria di Monserrato (Cagliari), 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibba</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3332-3845</Identifier><AffiliationInfo><Affiliation>Department of Medical, Surgical and Experimental Sciences, University of Sassari, Via Muroni, 23A, 07100 Sassari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biotechnology, Chemistry and Pharmacy, DoE Department of Excellence 2018-2022, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanna</LastName><ForeName>Giuseppina</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-3999-4263</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria di Monserrato (Cagliari), 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piras</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical, Surgical and Experimental Sciences, University of Sassari, Via Muroni, 23A, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riu</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical, Surgical and Experimental Sciences, University of Sassari, Via Muroni, 23A, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marongiu</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8513-9359</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria di Monserrato (Cagliari), 09042 Monserrato, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Sassari, Viale S. Pietro, 43C, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambrosino</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caria</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria di Monserrato (Cagliari), 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onnis</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-2438-725X</Identifier><AffiliationInfo><Affiliation>Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria di Monserrato (Cagliari), 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franci</LastName><ForeName>Gianluigi</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3321-4331</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Pathology and Microbiology Unit, San Giovanni di Dio e Ruggi D'Aragona University Hospital, 84131 Salerno, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manzin</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria di Monserrato (Cagliari), 09042 Monserrato, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carta</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical, Surgical and Experimental Sciences, University of Sassari, Via Muroni, 23A, 07100 Sassari, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>N° 2017M8R7N9</GrantID><Agency>PRIN 2017 "Natural and pharmacological inhibition of the early phase of viral replication (Vir-SudNet)</Agency><Country /></Grant><Grant><GrantID>no grant number</GrantID><Agency>Valere project of the University of Campania Luigi Vanvitelli</Agency><Country /></Grant><Grant><GrantID>FAR2020CARTAA</GrantID><Agency>University of Sassari, Fondo di ateneo per la ricerca (COEP)</Agency><Country /></Grant><Grant><GrantID>FAR2020PIRASS</GrantID><Agency>University of Sassari, Fondo di ateneo per la ricerca (COEP)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Pharmaceuticals (Basel)</MedlineTA><NlmUniqueID>101238453</NlmUniqueID><ISSNLinking>1424-8247</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA-binding protein database</Keyword><Keyword MajorTopicYN="N">antiviral activity</Keyword><Keyword MajorTopicYN="N">coxsackievirus B</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">quinoxaline derivatives</Keyword><Keyword MajorTopicYN="N">time of drug addiction</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>26</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35215294</ArticleId><ArticleId IdType="pmc">PMC8878107</ArticleId><ArticleId IdType="doi">10.3390/ph15020181</ArticleId><ArticleId IdType="pii">ph15020181</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Simmonds P., Gorbalenya A.E., Harvala H., Hovi T., Knowles N.J., Lindberg A.M., Oberste M.S., Palmenberg A.C., Reuter G., Skern T., et al. Recommendations for the Nomenclature of Enteroviruses and Rhinoviruses. Arch. Virol. 2020;165:793–797. doi: 10.1007/s00705-019-04520-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-019-04520-6</ArticleId><ArticleId IdType="pmc">PMC7024059</ArticleId><ArticleId IdType="pubmed">31980941</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherry J., Demmler-Harrison G., Kaplan S., Steinbach W., Hotez P. Feigin and Cherry’s Textbook of Pediatric Infectious Disease. 8th ed. Elsevier; Amsterdam, The Netherlands: 2017. pp. 1449–1542.</Citation></Reference><Reference><Citation>Abzug M.J. The Enteroviruses: Problems in Need of Treatments. J. Infect. 2014;68((Suppl.S1)):S108–S114. doi: 10.1016/j.jinf.2013.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2013.09.020</ArticleId><ArticleId IdType="pubmed">24119825</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim B.-K., Ju E.-S., Lao D.H., Yun S.-H., Lee Y.-J., Kim D.-K., Jeon E.-S. Development of a Enterovirus Diagnostic Assay System for Diagnosis of Viral Myocarditis in Humans. Microbiol. Immunol. 2013;57:281–287. doi: 10.1111/1348-0421.12028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1348-0421.12028</ArticleId><ArticleId IdType="pubmed">23586632</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesvaderani M., Eslick G.D., Cox M.R. Infectious Causes of Acute Pancreatitis. In: Eslick G.D., editor. Gastrointestinal Diseases and Their Associated Infections. 1st ed. Elsevier; Amsterdam, The Netherlands: 2019. pp. 55–66.</Citation></Reference><Reference><Citation>Chen H.-L., Tang R.-B. Why Zika Virus Infection Has Become a Public Health Concern? J. Chin. Med. Assoc. 2016;79:174–178. doi: 10.1016/j.jcma.2016.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcma.2016.03.001</ArticleId><ArticleId IdType="pubmed">27052792</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman N.M., Kim K.S. Persistent Coxsackievirus Infection: Enterovirus Persistence in Chronic Myocarditis and Dilated Cardiomyopathy. Curr. Top. Microbiol. Immunol. 2008;323:275–292.</Citation><ArticleIdList><ArticleId IdType="pubmed">18357775</ArticleId></ArticleIdList></Reference><Reference><Citation>Lugo D., Krogstad P. Enteroviruses in the Early 21st Century: New Manifestations and Challenges. Curr. Opin. Pediatr. 2016;28:107–113. doi: 10.1097/MOP.0000000000000303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000000303</ArticleId><ArticleId IdType="pmc">PMC4750492</ArticleId><ArticleId IdType="pubmed">26709690</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J., Thibaut H.J., Strating J.R.P.M., van Kuppeveld F.J.M. The Life Cycle of Non-Polio Enteroviruses and How to Target It. Nat. Rev. Microbiol. 2018;16:368–381. doi: 10.1038/s41579-018-0005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0005-4</ArticleId><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez G., Carr M.J., Kobayashi M., Hanaoka N., Fujimoto T. Enterovirus-Associated Hand-Foot and Mouth Disease and Neurological Complications in Japan and the Rest of the World. Int. J. Mol. Sci. 2019;20:5201. doi: 10.3390/ijms20205201.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205201</ArticleId><ArticleId IdType="pmc">PMC6834195</ArticleId><ArticleId IdType="pubmed">31635198</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrel C., Howard C., Murphy F. Fenner and White’s Medical Virology. 5th ed. Elsevier/Academic Press; Waltham, MA, USA: 2017. pp. 537–556.</Citation></Reference><Reference><Citation>Russell F., Laessig K. Safety and Efficacy Evaluation of Pleconaril for Treatment of the Common Cold. Clin. Infect. Dis. 2003;37:1722. doi: 10.1086/379830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/379830</ArticleId><ArticleId IdType="pubmed">14689362</ArticleId></ArticleIdList></Reference><Reference><Citation>De Palma A.M., Vliegen I., De Clercq E., Neyts J. Selective Inhibitors of Picornavirus Replication. Med. Res. Rev. 2008;28:823–884. doi: 10.1002/med.20125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.20125</ArticleId><ArticleId IdType="pubmed">18381747</ArticleId></ArticleIdList></Reference><Reference><Citation>Piras S., Corona P., Ibba R., Riu F., Murineddu G., Sanna G., Madeddu S., Delogu I., Loddo R., Carta A. Preliminary Anti-Coxsackie Activity of Novel 1-[4-(5,6-Dimethyl(H)-1H(2H)-Benzotriazol-1(2)-Yl)Phenyl]-3-Alkyl(Aryl)Ureas. Med. Chem. 2019;16:677–688. doi: 10.2174/1573406416666191226142744.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573406416666191226142744</ArticleId><ArticleId IdType="pubmed">31878859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibba R., Corona P., Carta A., Giunchedi P., Loddo R., Sanna G., Delogu I., Piras S. Antiviral Activities of 5-Chlorobenzotriazole Derivatives. Mon. Chem. 2018;149:1247–1256. doi: 10.1007/s00706-018-2234-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00706-018-2234-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Carta A., Sanna G., Briguglio I., Madeddu S., Vitale G., Piras S., Corona P., Peana A.T., Laurini E., Fermeglia M., et al. Quinoxaline Derivatives as New Inhibitors of Coxsackievirus B5. Eur. J. Med. Chem. 2018;145:559–569. doi: 10.1016/j.ejmech.2017.12.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2017.12.083</ArticleId><ArticleId IdType="pubmed">29339251</ArticleId></ArticleIdList></Reference><Reference><Citation>McKnight K.L., Heinz B.A. RNA as a Target for Developing Antivirals. Antivir. Chem. Chemother. 2003;14:61–73. doi: 10.1177/095632020301400201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/095632020301400201</ArticleId><ArticleId IdType="pubmed">12856917</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook K.B., Kazan H., Zuberi K., Morris Q., Hughes T.R. RBPDB: A Database of RNA-Binding Specificities. Nucleic Acids Res. 2011;39:D301–D308. doi: 10.1093/nar/gkq1069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkq1069</ArticleId><ArticleId IdType="pmc">PMC3013675</ArticleId><ArticleId IdType="pubmed">21036867</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin C., Manley J.L. The SR Protein SRp38 Represses Splicing in M Phase Cells. Cell. 2002;111:407–417. doi: 10.1016/S0092-8674(02)01038-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(02)01038-3</ArticleId><ArticleId IdType="pubmed">12419250</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowper A.E., Cáceres J.F., Mayeda A., Screaton G.R. Serine-Arginine (SR) Protein-like Factors That Antagonize Authentic SR Proteins and Regulate Alternative Splicing. J. Biol. Chem. 2001;276:48908–48914. doi: 10.1074/jbc.M103967200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M103967200</ArticleId><ArticleId IdType="pubmed">11684676</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud B., Horn C.M., Tapprich W.E. Structure of the 5’ Untranslated Region of Enteroviral Genomic RNA. J. Virol. 2019;93:e01288-19. doi: 10.1128/JVI.01288-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01288-19</ArticleId><ArticleId IdType="pmc">PMC6854513</ArticleId><ArticleId IdType="pubmed">31534036</ArticleId></ArticleIdList></Reference><Reference><Citation>Chabrolles H., Auclair H., Vegna S., Lahlali T., Pons C., Michelet M., Couté Y., Belmudes L., Chadeuf G., Kim Y., et al. Hepatitis B Virus Core Protein Nuclear Interactome Identifies SRSF10 as a Host RNA-Binding Protein Restricting HBV RNA Production. PLoS Pathog. 2020;16:e1008593. doi: 10.1371/journal.ppat.1008593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008593</ArticleId><ArticleId IdType="pmc">PMC7707522</ArticleId><ArticleId IdType="pubmed">33180834</ArticleId></ArticleIdList></Reference><Reference><Citation>Shkreta L., Blanchette M., Toutant J., Wilhelm E., Bell B., Story B.A., Balachandran A., Cochrane A., Cheung P.K., Harrigan P.R., et al. Modulation of the Splicing Regulatory Function of SRSF10 by a Novel Compound That Impairs HIV-1 Replication. Nucleic Acids Res. 2017;45:4051–4067. doi: 10.1093/nar/gkw1223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1223</ArticleId><ArticleId IdType="pmc">PMC5397194</ArticleId><ArticleId IdType="pubmed">27928057</ArticleId></ArticleIdList></Reference><Reference><Citation>Platt C., Calimano M., Nemet J., Bubenik J., Cochrane A. Differential Effects of Tra2ß Isoforms on HIV-1 RNA Processing and Expression. PLoS ONE. 2015;10:e0125315. doi: 10.1371/journal.pone.0125315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0125315</ArticleId><ArticleId IdType="pmc">PMC4430212</ArticleId><ArticleId IdType="pubmed">25970345</ArticleId></ArticleIdList></Reference><Reference><Citation>Purcell D.F., Martin M.A. Alternative Splicing of Human Immunodeficiency Virus Type 1 MRNA Modulates Viral Protein Expression, Replication, and Infectivity. J. Virol. 1993;67:6365–6378. doi: 10.1128/jvi.67.11.6365-6378.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.67.11.6365-6378.1993</ArticleId><ArticleId IdType="pmc">PMC238071</ArticleId><ArticleId IdType="pubmed">8411338</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong R., Balachandran A., Mao A.Y., Dobson W., Gray-Owen S., Cochrane A. Differential Effect of CLK SR Kinases on HIV-1 Gene Expression: Potential Novel Targets for Therapy. Retrovirology. 2011;8:47. doi: 10.1186/1742-4690-8-47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4690-8-47</ArticleId><ArticleId IdType="pmc">PMC3148977</ArticleId><ArticleId IdType="pubmed">21682887</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauwels R., Balzarini J., Baba M., Snoeck R., Schols D., Herdewijn P., Desmyter J., De Clercq E. Rapid and Automated Tetrazolium-Based Colorimetric Assay for the Detection of Anti-HIV Compounds. J. Virol. Methods. 1988;20:309–321. doi: 10.1016/0166-0934(88)90134-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-0934(88)90134-6</ArticleId><ArticleId IdType="pubmed">2460479</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanna G., Madeddu S., Murgia G., Serreli G., Begala M., Caboni P., Incani A., Franci G., Galdiero M., Giliberti G. Potent and Selective Activity against Human Immunodeficiency Virus 1 (HIV-1) of Thymelaea Hirsuta Extracts. Viruses. 2020;12:664. doi: 10.3390/v12060664.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12060664</ArticleId><ArticleId IdType="pmc">PMC7354558</ArticleId><ArticleId IdType="pubmed">32575585</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibba R., Carta A., Madeddu S., Caria P., Serreli G., Piras S., Sestito S., Loddo R., Sanna G. Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative. Viruses. 2021;13:58. doi: 10.3390/v13010058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010058</ArticleId><ArticleId IdType="pmc">PMC7823780</ArticleId><ArticleId IdType="pubmed">33406781</ArticleId></ArticleIdList></Reference><Reference><Citation>Madeira F., Park Y.M., Lee J., Buso N., Gur T., Madhusoodanan N., Basutkar P., Tivey A.R.N., Potter S.C., Finn R.D., et al. The EMBL-EBI Search and Sequence Analysis Tools APIs in 2019. Nucleic Acids Res. 2019;47:W636–W641. doi: 10.1093/nar/gkz268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz268</ArticleId><ArticleId IdType="pmc">PMC6602479</ArticleId><ArticleId IdType="pubmed">30976793</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey T.L., Gribskov M. Combining Evidence Using P-Values: Application to Sequence Homology Searches. Bioinformatics. 1998;14:48–54. doi: 10.1093/bioinformatics/14.1.48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/14.1.48</ArticleId><ArticleId IdType="pubmed">9520501</ArticleId></ArticleIdList></Reference><Reference><Citation>Heberle H., Meirelles G.V., da Silva F.R., Telles G.P., Minghim R. InteractiVenn: A Web-Based Tool for the Analysis of Sets through Venn Diagrams. BMC Bioinform. 2015;16:169. doi: 10.1186/s12859-015-0611-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-015-0611-3</ArticleId><ArticleId IdType="pmc">PMC4455604</ArticleId><ArticleId IdType="pubmed">25994840</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Morris J.H., Cook H., Kuhn M., Wyder S., Simonovic M., Santos A., Doncheva N.T., Roth A., Bork P., et al. The STRING Database in 2017: Quality-Controlled Protein-Protein Association Networks, Made Broadly Accessible. Nucleic Acids Res. 2017;45:D362–D368. doi: 10.1093/nar/gkw937.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw937</ArticleId><ArticleId IdType="pmc">PMC5210637</ArticleId><ArticleId IdType="pubmed">27924014</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>